Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, however our understanding of cell specific mechanisms underlying COPD pathobiology remains incomplete. Here, we analyze single-cell RNA sequencing profiles of explanted lung tissue from subjects with advanced COPD or control lungs, and we validate findings using single-cell RNA sequencing of lungs from mice exposed to 10 months of cigarette smoke, RNA sequencing of isolated human alveolar epithelial cells, functional in vitro models, and in situ hybridization and immunostaining of human lung tissue samples. We identify a subpopulation of alveolar epithelial type II cells with transcriptional evidence for aberrant cellular metabolism and reduced cellular stress tolerance in COPD. Using transcriptomic network analyses, we predict capillary endothelial cells are inflamed in COPD, particularly through increased CXCL-motif chemokine signaling. Finally, we detect a high-metallothionein expressing macrophage subpopulation enriched in advanced COPD. Collectively, these findings highlight cell-specific mechanisms involved in the pathobiology of advanced COPD.

Chronic obstructive pulmonary disease is a leading cause of death worldwide, while our understanding of cell-specific mechanisms underlying its pathobiology remains incomplete. Here the authors perform scRNA-seq of human lung tissue to identify transcriptional changes in alveolar niche cells associated with the disease.

Details

Title
Characterization of the COPD alveolar niche using single-cell RNA sequencing
Author
Maor, Sauler 1   VIAFID ORCID Logo  ; McDonough, John E 1 ; Adams, Taylor S 1 ; Kothapalli Neeharika 1 ; Barnthaler, Thomas 2 ; Werder, Rhiannon B 3 ; Schupp, Jonas C 4   VIAFID ORCID Logo  ; Nouws Jessica 1 ; Robertson, Matthew J 5 ; Coarfa Cristian 5   VIAFID ORCID Logo  ; Yang, Tao 6 ; Chioccioli Maurizio 1 ; Omote Norihito 1 ; Carlos, Cosme, Jr 1 ; Poli, Sergio 7   VIAFID ORCID Logo  ; Ayaub, Ehab A 8 ; Chu, Sarah G 8 ; Jensen, Klaus H 9   VIAFID ORCID Logo  ; Gomez, Jose L 1   VIAFID ORCID Logo  ; Britto, Clemente J 1   VIAFID ORCID Logo  ; Raredon Micha Sam B 10   VIAFID ORCID Logo  ; Niklason, Laura E 11 ; Wilson, Andrew A 12 ; Timshel, Pascal N 13 ; Kaminski Naftali 1   VIAFID ORCID Logo  ; Rosas, Ivan O 5 

 Yale School of Medicine, Pulmonary, Critical Care and Sleep Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Yale School of Medicine, Pulmonary, Critical Care and Sleep Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Medical University of Graz, Division of Pharmacology, Otto Loewi Research Center, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476) 
 Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745); Boston University School of Medicine, The Pulmonary Center and Department of Medicine, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558); QIMR Berghofer Medical Research Institute, Herston, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
 Yale School of Medicine, Pulmonary, Critical Care and Sleep Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); German Lung Research Center (DZL), Department of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease Hannover, Hannover, Germany (GRID:grid.47100.32) 
 Baylor College of Medicine, Pulmonary, Critical Care and Sleep Medicine, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X) 
 Yale School of Medicine, Pulmonary, Critical Care and Sleep Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); The First Affiliated Hospital of Chongqing Medical University, Department of Thoracic and Cardiovascular Surgery, Chongqing, China (GRID:grid.452206.7) (ISNI:0000 0004 1758 417X) 
 Mount Sinai Medical Center, Department of Internal Medicine, Miami, USA (GRID:grid.410396.9) (ISNI:0000 0004 0430 4458) 
 Brigham and Women’s Hospital, Harvard Medical School, Division of Pulmonary and Critical Care Medicine, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Intomics A/S, Lyngby, Denmark (GRID:grid.38142.3c) 
10  Yale University, Department of Biomedical Engineering, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale School of Medicine, Medical Scientist Training Program, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
11  Yale University, Department of Biomedical Engineering, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
12  Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745); Boston University School of Medicine, The Pulmonary Center and Department of Medicine, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558) 
13  Intomics A/S, Lyngby, Denmark (GRID:grid.189504.1) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2622675998
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.